Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review
Authors
Keywords
-
Journal
DRUG DEVELOPMENT RESEARCH
Volume 76, Issue 6, Pages 296-317
Publisher
Wiley
Online
2015-08-25
DOI
10.1002/ddr.21268
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II study of the histone-deacetylase inhibitor ITF2357 in relapsed/refractory Hodgkin’s lymphoma patients
- (2017) S. Viviani et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation
- (2015) S. Fu et al. ANNALS OF ONCOLOGY
- ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
- (2015) S. Meidhof et al. EMBO Molecular Medicine
- A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
- (2015) R. Chen et al. HAEMATOLOGICA
- MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence
- (2015) Joon-Ho Cho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-Cancer Drugs Reactivate Tumor Suppressor miR-375 Expression in Tongue Cancer Cells
- (2015) Hyun Min Jung et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer
- (2015) David R. Li et al. JOURNAL OF UROLOGY
- HDAC Inhibitors Target HDAC5, Upregulate MicroRNA-125a-5p, and Induce Apoptosis in Breast Cancer Cells
- (2015) Tsung-Hua Hsieh et al. MOLECULAR THERAPY
- Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells
- (2015) Mark O. Kitchen et al. Pituitary
- miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer
- (2015) Xiaoyu Zhang et al. Oncotarget
- A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
- (2015) R. Chen et al. HAEMATOLOGICA
- Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome
- (2015) Oncotarget
- A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia
- (2014) Michael J. Burke et al. AMERICAN JOURNAL OF HEMATOLOGY
- Valproic acid regulates erythro-megakaryocytic differentiation through the modulation of transcription factors and microRNA regulatory micro-networks
- (2014) Anne Trécul et al. BIOCHEMICAL PHARMACOLOGY
- Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
- (2014) H Yang et al. BRITISH JOURNAL OF CANCER
- A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome
- (2014) Mark Kirschbaum et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma
- (2014) Edwin Choy et al. CANCER
- Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes
- (2014) Hyang Sook Seol et al. CANCER LETTERS
- Dietary Manipulation of Oncogenic MicroRNA Expression in Human Rectal Mucosa: A Randomized Trial
- (2014) K. J. Humphreys et al. Cancer Prevention Research
- An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration
- (2014) Raghu R. Chivukula et al. CELL
- Epigenetics in Vascular Disease – Therapeutic Potential of New Agents
- (2014) Simon Xu et al. Current Vascular Pharmacology
- Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis
- (2014) Prasun J Mishra EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer
- (2014) Zheng Li et al. Gastric Cancer
- Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis
- (2014) Lauren R. Zeitels et al. GENES & DEVELOPMENT
- microRNA-7: A tumor suppressor miRNA with therapeutic potential
- (2014) Felicity C. Kalinowski et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas
- (2014) Roberta Zappasodi et al. INTERNATIONAL JOURNAL OF CANCER
- Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905
- (2014) Thomas Prebet et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer
- (2014) Yougang Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
- (2014) Jesús F San-Miguel et al. LANCET ONCOLOGY
- Lithium/Valproic Acid Combination and l-Glutamate Induce Similar Pattern of Changes in the Expression of miR-30a-5p in SH-SY5Y Neuroblastoma Cells
- (2014) Nicoletta Croce et al. NEUROMOLECULAR MEDICINE
- MicroRNA-219-2-3p Functions as a Tumor Suppressor in Gastric Cancer and Is Regulated by DNA Methylation
- (2014) Huizi Lei et al. PLoS One
- MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate
- (2014) Lena Smirnova et al. PLoS One
- MicroRNA-34a: a potential therapeutic target in human cancer
- (2014) X J Li et al. Cell Death & Disease
- Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2014) P Tan et al. Blood Cancer Journal
- Trichostatin A Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells
- (2014) Chih-Yen Tu et al. Biomed Research International
- Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
- (2014) S Hibino et al. Oncogenesis
- Epigenetic regulation of microRNA expression in renal cell carcinoma
- (2013) Miriam Schiffgen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia
- (2013) I. M. Ghobrial et al. BLOOD
- Cancers with wrong HATs: the impact of acetylation
- (2013) V. Di Cerbo et al. Briefings in Functional Genomics
- Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma
- (2013) N Nohata et al. BRITISH JOURNAL OF CANCER
- Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells
- (2013) Namita Chatterjee et al. CANCER BIOLOGY & THERAPY
- miR-1 Induces Growth Arrest and Apoptosis in Malignant Mesothelioma
- (2013) Yue Xu et al. CHEST
- Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia
- (2013) I. Gojo et al. CLINICAL CANCER RESEARCH
- Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers
- (2013) L. Amiri-Kordestani et al. CLINICAL CANCER RESEARCH
- Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression
- (2013) Ashish Saxena et al. EUROPEAN JOURNAL OF CANCER
- The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer
- (2013) Li-Hua Guo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors
- (2013) Dustin A. Deming et al. INVESTIGATIONAL NEW DRUGS
- Up-regulation of miR-146b and Down-regulation of miR-200b Contribute to the Cytotoxic Effect of Histone Deacetylase Inhibitors onras-Transformed Thyroid Cells
- (2013) Eleonora Borbone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies
- (2013) D J DeAngelo et al. LEUKEMIA
- Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer
- (2013) Chi-qi Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Histone Deacetylase Inhibition Overcomes Drug Resistance through a miRNA-Dependent Mechanism
- (2013) T. Murray-Stewart et al. MOLECULAR CANCER THERAPEUTICS
- The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines
- (2013) Alexander Henrici et al. MOLECULAR CARCINOGENESIS
- Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish
- (2013) Neelakanteswar Aluru et al. NEUROTOXICOLOGY AND TERATOLOGY
- Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
- (2013) Tissa T. Manavalan et al. PLoS One
- miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer
- (2013) Min Deng et al. PLoS One
- MiR-376c Down-Regulation Accelerates EGF-Dependent Migration by Targeting GRB2 in the HuCCT1 Human Intrahepatic Cholangiocarcinoma Cell Line
- (2013) Jun Iwaki et al. PLoS One
- Tumor Suppressive Function of mir-205 in Breast Cancer Is Linked to HMGB3 Regulation
- (2013) Ola A. Elgamal et al. PLoS One
- miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
- (2013) Rounak Nassirpour et al. PLoS One
- HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
- (2013) Ilaria Lepore et al. PLoS One
- Functional cooperation of miR-125a, miR-125b and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
- (2013) S Wang et al. Cell Death & Disease
- Up-Regulation of miR-182 Expression after Epigenetic Modulation of Human Melanoma Cells
- (2012) Suhu Liu et al. ANNALS OF SURGICAL ONCOLOGY
- Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs
- (2012) Yoshimasa Saito et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chromatin-modifying agents in anti-cancer therapy
- (2012) Carole Seidel et al. BIOCHIMIE
- A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells
- (2012) Curt Balch et al. CANCER BIOLOGY & THERAPY
- The MicroRNA-17-92 Family of MicroRNA Clusters in Development and Disease
- (2012) Carla P. Concepcion et al. CANCER JOURNAL
- Down-regulation of miR-517a and miR-517c promotes proliferation of hepatocellular carcinoma cells via targeting Pyk2
- (2012) Rui-Fang Liu et al. CANCER LETTERS
- MicroRNAs in Stress Signaling and Human Disease
- (2012) Joshua T. Mendell et al. CELL
- Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non-Small Cell Lung Cancers
- (2012) G. Heller et al. CLINICAL CANCER RESEARCH
- Histone deacetylase 1 enhances microRNA processing via deacetylation of DGCR8
- (2012) Taeko Wada et al. EMBO REPORTS
- Methylation of a Panel of MicroRNA Genes Is a Novel Biomarker for Detection of Bladder Cancer
- (2012) Takashi Shimizu et al. EUROPEAN UROLOGY
- Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines
- (2012) Pietro Di Fazio et al. EXPERIMENTAL CELL RESEARCH
- Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells
- (2012) Reena Buurman et al. GASTROENTEROLOGY
- Identification of Metastamirs as Metastasis-associated MicroRNAs in Clear Cell Renal Cell Carcinomas
- (2012) Zofia Wotschofsky et al. International Journal of Biological Sciences
- Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy
- (2012) Samir E. Witta et al. JOURNAL OF CLINICAL ONCOLOGY
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice
- (2012) Takuya Kitamura et al. JOURNAL OF HEPATOLOGY
- miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo
- (2012) Mirjam B. Zeisel et al. JOURNAL OF HEPATOLOGY
- MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application
- (2012) Muhammad Imran Aslam et al. Journal of Translational Medicine
- Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia
- (2012) A Mims et al. LEUKEMIA
- Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster
- (2012) Karen J. Humphreys et al. MOLECULAR CARCINOGENESIS
- The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes
- (2012) R. B. Donker et al. MOLECULAR HUMAN REPRODUCTION
- A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts
- (2012) Judit Ribas et al. NUCLEIC ACIDS RESEARCH
- TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC
- (2012) Zhi-Ning Zhao et al. PLoS One
- Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell Lines
- (2012) Venugopal Thayanithy et al. PLoS One
- A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma
- (2011) S. J. Harrison et al. BLOOD
- Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
- (2011) D. Sampath et al. BLOOD
- Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours
- (2011) R Pili et al. BRITISH JOURNAL OF CANCER
- A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer
- (2011) M. G. Fakih et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels
- (2011) L. Kretzner et al. CANCER RESEARCH
- Genome-wide Profiling of Chromatin Signatures Reveals Epigenetic Regulation of MicroRNA Genes in Colorectal Cancer
- (2011) H. Suzuki et al. CANCER RESEARCH
- MicroRNA-21 and PDCD4 expression in colorectal cancer
- (2011) K.H. Chang et al. EJSO
- MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells
- (2011) Patrick Brest et al. ENDOCRINE-RELATED CANCER
- Epigenetic regulation of microRNA-375 and its role in melanoma development in humans
- (2011) Joseph Mazar et al. FEBS LETTERS
- Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines
- (2011) Jianzhen Xu et al. INTERNATIONAL JOURNAL OF CANCER
- miR-200a Regulates Nrf2 Activation by TargetingKeap1mRNA in Breast Cancer Cells
- (2011) Gabriel Eades et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
- (2011) Anas Younes et al. LANCET ONCOLOGY
- Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma
- (2011) Bevin Zimmerman et al. LEUKEMIA RESEARCH
- Extracellular microRNA: A new source of biomarkers
- (2011) Alton Etheridge et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas
- (2011) X Zhang et al. ONCOGENE
- Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer
- (2011) Hajime Shibuya et al. ONCOLOGY
- The Microbe-Derived Short Chain Fatty Acid Butyrate Targets miRNA-Dependent p21 Gene Expression in Human Colon Cancer
- (2011) Shien Hu et al. PLoS One
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
- (2011) Andrea Kuendgen et al. Clinical Epigenetics
- The functional significance of microRNA-145 in prostate cancer
- (2010) M S Zaman et al. BRITISH JOURNAL OF CANCER
- Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect
- (2010) Hiromu Suzuki et al. CARCINOGENESIS
- mir-17-92, a cluster of miRNAs in the midst of the cancer network
- (2010) Virginie Olive et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells
- (2010) Shuhong Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer
- (2010) Hanna E. Rauhala et al. INTERNATIONAL JOURNAL OF CANCER
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
- (2010) Jaime Coronel et al. MEDICAL ONCOLOGY
- OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
- (2010) Pedro P. Medina et al. NATURE
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo
- (2010) David M. Lucas et al. PLoS One
- MiRNA profile in esophageal squamous cell carcinoma: Downregulation of miR-143 and miR-145
- (2010) Bing-Li Wu WORLD JOURNAL OF GASTROENTEROLOGY
- A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma
- (2009) Monica Galli et al. ANNALS OF HEMATOLOGY
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer
- (2009) Greg M Arndt et al. BMC CANCER
- Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia
- (2009) X. Agirre et al. CANCER RESEARCH
- miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
- (2009) R I Aqeilan et al. CELL DEATH AND DIFFERENTIATION
- miR-19 is a key oncogenic component of mir-17-92
- (2009) V. Olive et al. GENES & DEVELOPMENT
- Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b
- (2009) K. Todoerti et al. HAEMATOLOGICA
- Epigenetic regulation of microRNA expression in colorectal cancer
- (2009) Eva Bandres et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers
- (2009) Takeshi Takagi et al. ONCOLOGY
- Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer
- (2009) Kwang-Hyuck Lee et al. PANCREATOLOGY
- miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice
- (2009) Cyrielle Clapé et al. PLoS One
- Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells
- (2008) Yoshimasa Saito et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia
- (2008) G. Garcia-Manero et al. BLOOD
- Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
- (2008) María J. Bueno et al. CANCER CELL
- Emerging Role of miR-106b-25/miR-17-92 Clusters in the Control of Transforming Growth Factor Signaling
- (2008) F. Petrocca et al. CANCER RESEARCH
- Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular Carcinogenesis
- (2008) J. Datta et al. CANCER RESEARCH
- Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Zn(II)-dependent histone deacetylase inhibitors: Suberoylanilide hydroxamic acid and trichostatin A
- (2008) Rachel Codd et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors
- (2008) Lillian L. Siu et al. JOURNAL OF CLINICAL ONCOLOGY
- Array-based analysis of the effects of trichostatin A and CG-1521 on cell cycle and cell death in LNCaP prostate cancer cells
- (2008) S. Roy et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer
- (2008) W M Grady et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started